Selected research
Industry Research
Viral Detection Industry Research Report 2026
Market perspective
The global Viral Detection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Viral Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Viral Detection market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Viral Detection market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Viral Detection include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene and Intertek, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Viral Detection market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Viral Detection.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Viral Detection Market by Company
Merck KGaA
Charles River Laboratories
Eurofins
SGS
Sartorius
Asahi Kasei
Samsung Biologics
Syngene
Intertek
Minaris Advanced Therapies
Texcell
PathoQuest
Clean Cells
Avance Biosciences
Microbiologics
Alcami
Creative Biolabs
Creative Biogene
WuXi AppTec
WuXi Biologics
Viral Detection Segment by Type
Plaque Assays
PCR
ELISA
Others
Viral Detection Segment by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Viral Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Viral Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plaque Assays
- PCR
- ELISA
- Others
Applications
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines and Therapeutics
Companies covered
- Merck KGaA
- Charles River Laboratories
- Eurofins
- SGS
- Sartorius
- Asahi Kasei
- Samsung Biologics
- Syngene
- Intertek
- Minaris Advanced Therapies
- Texcell
- PathoQuest
- Clean Cells
- Avance Biosciences
- Microbiologics
- Alcami
- Creative Biolabs
- Creative Biogene
- WuXi AppTec
- WuXi Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Viral Detection by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Plaque Assays
- 2.2.3 PCR
- 2.2.4 ELISA
- 2.2.5 Others
- 2.3 Viral Detection by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Blood & Blood Products
- 2.3.3 Cellular & Gene Therapy Products
- 2.3.4 Stem Cell Products
- 2.3.5 Tissue & Tissue Products
- 2.3.6 Vaccines and Therapeutics
- 2.4 Assumptions and Limitations
3 Viral Detection Breakdown Data by Type
- 3.1 Global Viral Detection Historic Market Size by Type (2021-2026)
- 3.2 Global Viral Detection Forecasted Market Size by Type (2027-2032)
4 Viral Detection Breakdown Data by Application
- 4.1 Global Viral Detection Historic Market Size by Application (2021-2026)
- 4.2 Global Viral Detection Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Viral Detection Market Perspective (2021-2032)
- 5.2 Global Viral Detection Growth Trends by Region
- 5.2.1 Global Viral Detection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Viral Detection Historic Market Size by Region (2021-2026)
- 5.2.3 Viral Detection Forecasted Market Size by Region (2027-2032)
- 5.3 Viral Detection Market Dynamics
- 5.3.1 Viral Detection Industry Trends
- 5.3.2 Viral Detection Market Drivers
- 5.3.3 Viral Detection Market Challenges
- 5.3.4 Viral Detection Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Viral Detection Players by Revenue
- 6.1.1 Global Top Viral Detection Players by Revenue (2021-2026)
- 6.1.2 Global Viral Detection Revenue Market Share by Players (2021-2026)
- 6.2 Global Viral Detection Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Viral Detection Head Office and Area Served
- 6.4 Global Viral Detection Players, Product Type & Application
- 6.5 Global Viral Detection Manufacturers Established Date
- 6.6 Global Viral Detection Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Viral Detection Market Size (2021-2032)
- 7.2 North America Viral Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Viral Detection Market Size by Country (2021-2026)
- 7.4 North America Viral Detection Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Viral Detection Market Size (2021-2032)
- 8.2 Europe Viral Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Viral Detection Market Size by Country (2021-2026)
- 8.4 Europe Viral Detection Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Viral Detection Market Size (2021-2032)
- 9.2 Asia-Pacific Viral Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Viral Detection Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Viral Detection Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Viral Detection Market Size (2021-2032)
- 10.2 South America Viral Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Viral Detection Market Size by Country (2021-2026)
- 10.4 South America Viral Detection Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Viral Detection Market Size (2021-2032)
- 11.2 Middle East & Africa Viral Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Viral Detection Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Viral Detection Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck KGaA
- 12.1.1 Merck KGaA Company Information
- 12.1.2 Merck KGaA Business Overview
- 12.1.3 Merck KGaA Revenue in Viral Detection Business (2021-2026)
- 12.1.4 Merck KGaA Viral Detection Product Portfolio
- 12.1.5 Merck KGaA Recent Developments
- 12.2 Charles River Laboratories
- 12.2.1 Charles River Laboratories Company Information
- 12.2.2 Charles River Laboratories Business Overview
- 12.2.3 Charles River Laboratories Revenue in Viral Detection Business (2021-2026)
- 12.2.4 Charles River Laboratories Viral Detection Product Portfolio
- 12.2.5 Charles River Laboratories Recent Developments
- 12.3 Eurofins
- 12.3.1 Eurofins Company Information
- 12.3.2 Eurofins Business Overview
- 12.3.3 Eurofins Revenue in Viral Detection Business (2021-2026)
- 12.3.4 Eurofins Viral Detection Product Portfolio
- 12.3.5 Eurofins Recent Developments
- 12.4 SGS
- 12.4.1 SGS Company Information
- 12.4.2 SGS Business Overview
- 12.4.3 SGS Revenue in Viral Detection Business (2021-2026)
- 12.4.4 SGS Viral Detection Product Portfolio
- 12.4.5 SGS Recent Developments
- 12.5 Sartorius
- 12.5.1 Sartorius Company Information
- 12.5.2 Sartorius Business Overview
- 12.5.3 Sartorius Revenue in Viral Detection Business (2021-2026)
- 12.5.4 Sartorius Viral Detection Product Portfolio
- 12.5.5 Sartorius Recent Developments
- 12.6 Asahi Kasei
- 12.6.1 Asahi Kasei Company Information
- 12.6.2 Asahi Kasei Business Overview
- 12.6.3 Asahi Kasei Revenue in Viral Detection Business (2021-2026)
- 12.6.4 Asahi Kasei Viral Detection Product Portfolio
- 12.6.5 Asahi Kasei Recent Developments
- 12.7 Samsung Biologics
- 12.7.1 Samsung Biologics Company Information
- 12.7.2 Samsung Biologics Business Overview
- 12.7.3 Samsung Biologics Revenue in Viral Detection Business (2021-2026)
- 12.7.4 Samsung Biologics Viral Detection Product Portfolio
- 12.7.5 Samsung Biologics Recent Developments
- 12.8 Syngene
- 12.8.1 Syngene Company Information
- 12.8.2 Syngene Business Overview
- 12.8.3 Syngene Revenue in Viral Detection Business (2021-2026)
- 12.8.4 Syngene Viral Detection Product Portfolio
- 12.8.5 Syngene Recent Developments
- 12.9 Intertek
- 12.9.1 Intertek Company Information
- 12.9.2 Intertek Business Overview
- 12.9.3 Intertek Revenue in Viral Detection Business (2021-2026)
- 12.9.4 Intertek Viral Detection Product Portfolio
- 12.9.5 Intertek Recent Developments
- 12.10 Minaris Advanced Therapies
- 12.10.1 Minaris Advanced Therapies Company Information
- 12.10.2 Minaris Advanced Therapies Business Overview
- 12.10.3 Minaris Advanced Therapies Revenue in Viral Detection Business (2021-2026)
- 12.10.4 Minaris Advanced Therapies Viral Detection Product Portfolio
- 12.10.5 Minaris Advanced Therapies Recent Developments
- 12.11 Texcell
- 12.11.1 Texcell Company Information
- 12.11.2 Texcell Business Overview
- 12.11.3 Texcell Revenue in Viral Detection Business (2021-2026)
- 12.11.4 Texcell Viral Detection Product Portfolio
- 12.11.5 Texcell Recent Developments
- 12.12 PathoQuest
- 12.12.1 PathoQuest Company Information
- 12.12.2 PathoQuest Business Overview
- 12.12.3 PathoQuest Revenue in Viral Detection Business (2021-2026)
- 12.12.4 PathoQuest Viral Detection Product Portfolio
- 12.12.5 PathoQuest Recent Developments
- 12.13 Clean Cells
- 12.13.1 Clean Cells Company Information
- 12.13.2 Clean Cells Business Overview
- 12.13.3 Clean Cells Revenue in Viral Detection Business (2021-2026)
- 12.13.4 Clean Cells Viral Detection Product Portfolio
- 12.13.5 Clean Cells Recent Developments
- 12.14 Avance Biosciences
- 12.14.1 Avance Biosciences Company Information
- 12.14.2 Avance Biosciences Business Overview
- 12.14.3 Avance Biosciences Revenue in Viral Detection Business (2021-2026)
- 12.14.4 Avance Biosciences Viral Detection Product Portfolio
- 12.14.5 Avance Biosciences Recent Developments
- 12.15 Microbiologics
- 12.15.1 Microbiologics Company Information
- 12.15.2 Microbiologics Business Overview
- 12.15.3 Microbiologics Revenue in Viral Detection Business (2021-2026)
- 12.15.4 Microbiologics Viral Detection Product Portfolio
- 12.15.5 Microbiologics Recent Developments
- 12.16 Alcami
- 12.16.1 Alcami Company Information
- 12.16.2 Alcami Business Overview
- 12.16.3 Alcami Revenue in Viral Detection Business (2021-2026)
- 12.16.4 Alcami Viral Detection Product Portfolio
- 12.16.5 Alcami Recent Developments
- 12.17 Creative Biolabs
- 12.17.1 Creative Biolabs Company Information
- 12.17.2 Creative Biolabs Business Overview
- 12.17.3 Creative Biolabs Revenue in Viral Detection Business (2021-2026)
- 12.17.4 Creative Biolabs Viral Detection Product Portfolio
- 12.17.5 Creative Biolabs Recent Developments
- 12.18 Creative Biogene
- 12.18.1 Creative Biogene Company Information
- 12.18.2 Creative Biogene Business Overview
- 12.18.3 Creative Biogene Revenue in Viral Detection Business (2021-2026)
- 12.18.4 Creative Biogene Viral Detection Product Portfolio
- 12.18.5 Creative Biogene Recent Developments
- 12.19 WuXi AppTec
- 12.19.1 WuXi AppTec Company Information
- 12.19.2 WuXi AppTec Business Overview
- 12.19.3 WuXi AppTec Revenue in Viral Detection Business (2021-2026)
- 12.19.4 WuXi AppTec Viral Detection Product Portfolio
- 12.19.5 WuXi AppTec Recent Developments
- 12.20 WuXi Biologics
- 12.20.1 WuXi Biologics Company Information
- 12.20.2 WuXi Biologics Business Overview
- 12.20.3 WuXi Biologics Revenue in Viral Detection Business (2021-2026)
- 12.20.4 WuXi Biologics Viral Detection Product Portfolio
- 12.20.5 WuXi Biologics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst